These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12510990

  • 1. Skeletal consequences of discontinuation of growth hormone at final height.
    Drake WM, Carroll PV, Savage MO, Monson JP.
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1351-4. PubMed ID: 12510990
    [Abstract] [Full Text] [Related]

  • 2. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G, Corneli G, Rovere S, Croce CG, Ghigo E, Procopio M.
    J Endocrinol Invest; 2005 Dec; 28(10 Suppl):28-32. PubMed ID: 16550719
    [Abstract] [Full Text] [Related]

  • 3. Effect of GH treatment on bone mass in children with GH deficiency.
    Baroncelli GI, Saggese G.
    J Endocrinol Invest; 2005 Dec; 28(10 Suppl):23-7. PubMed ID: 16550718
    [Abstract] [Full Text] [Related]

  • 4. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth.
    Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hübner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1658-63. PubMed ID: 12679453
    [Abstract] [Full Text] [Related]

  • 5. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov 15; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM, van der Sluis IM, Krenning EP, de Muinck Keizer-Schrama SM.
    Horm Res; 2009 Nov 15; 71(6):364-71. PubMed ID: 19506395
    [Abstract] [Full Text] [Related]

  • 8. Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency.
    Baroncelli GI, Bertelloni S, Sodini F, Saggese G.
    J Pediatr Endocrinol Metab; 2003 Mar 15; 16 Suppl 2():327-35. PubMed ID: 12729412
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May 15; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone and bone.
    Tritos NA, Biller BM.
    Curr Opin Endocrinol Diabetes Obes; 2009 Dec 15; 16(6):415-22. PubMed ID: 19770650
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Dec 15; 12(1):31-4. PubMed ID: 16704859
    [Abstract] [Full Text] [Related]

  • 12. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug 15; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 13. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May 15; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 14. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May 15; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 15. GH deficiency in the adult and bone.
    Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A.
    J Endocrinol Invest; 2005 May 15; 28(8 Suppl):18-23. PubMed ID: 16323825
    [Abstract] [Full Text] [Related]

  • 16. A lifetime of growth hormone deficiency: a US pediatric perspective.
    Saenger P.
    J Pediatr Endocrinol Metab; 2000 May 15; 13 Suppl 6():1337-42. PubMed ID: 11202206
    [Abstract] [Full Text] [Related]

  • 17. Adolescents with childhood-onset GHD: how do we get them to peak bone mass?
    Shalet S.
    Horm Res; 2006 May 15; 65 Suppl 2():17-22. PubMed ID: 16707905
    [Abstract] [Full Text] [Related]

  • 18. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec 15; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 19. Transition of childhood-onset growth hormone-deficient patients to adult healthcare.
    Rapaport R, Cook DM.
    Pediatr Endocrinol Rev; 2006 Dec 15; 4 Suppl 1():82-90. PubMed ID: 17261975
    [Abstract] [Full Text] [Related]

  • 20. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2006 Jul 15; 43(7):593-9. PubMed ID: 16891678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.